Robert C. Getts
Direktor/Vorstandsmitglied bei Genisphere LLC
Profil
Robert C.
Getts is currently a Director at Genisphere LLC.
Previously, he worked as a Principal at Philadelphia College of Osteopathic Medicine.
He holds a doctorate degree from Lehigh University and undergraduate and graduate degrees from the University of Scranton.
Aktive Positionen von Robert C. Getts
Unternehmen | Position | Beginn |
---|---|---|
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert C. Getts
Unternehmen | Position | Ende |
---|---|---|
Philadelphia College of Osteopathic Medicine | Corporate Officer/Principal | - |
Ausbildung von Robert C. Getts
University of Scranton | Graduate Degree |
Lehigh University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Technology |